Last $98.65 USD
Change Today -2.76 / -2.72%
Volume 2.0M
AGN On Other Exchanges
Symbol
Exchange
New York
Berlin
As of 3:16 PM 05/20/13 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

David J. Endicott

Corporate Vice President and President of Allergan Medical, Asia Pacific & Latin America, Allergan Inc.
AgeTotal Calculated CompensationThis person is connected to 9 board members in 1 different organizations across 2 different industries.

See Board Relationships
47$2,736,602
As of Fiscal Year 2012

Background*

Mr. David J. Endicott has been a Corporate Vice President and President, Allergan Medical, Asia Pacific and Latin America at Allergan Inc. since April 2011. Mr. Endicott served as Corporate Vice President and President of Allergan Medical at Allergan, Inc. since August 2010. He served as Corporate Vice President and President of Europe, Africa and Middle East at Allergan, Inc. from October 2004 to August 2010 and managed the expansion of Allergan's business internationally, ...

Read Full Background

Corporate Headquarters*

2525 Dupont Drive
Irvine, California 92612

United States

Phone: 714-246-4500
Fax: 714-246-6987

Board Members Memberships*

2012-Present
Director

Education*

MBA
University of Southern California
Unknown/Other Education
Whitman College

Other Affiliations*

Annual Compensation*

Salary$540,000
Total Annual Compensation$540,000

Stock Options*

Restricted Stock Awards$33,230
All Other Compensation$50,862
Exercised Options82,000
Exercised Options Value$2,756,330
Exercisable Options13,000
Exercisable Options Value$209,950
Unexercisable Options132,000
Unexercisable Options Value$2,420,860
Total Value of Options$5,387,140
Total Number of Options227,000

Total Compensation*

Total Annual Cash Compensation$888,962
Total Short Term Compensation$540,000
Other Long Term Compensation$84,092
Total Calculated Compensation$2,736,602
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AGN:US $98.65 USD -2.76

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Leonard S. Schleifer M.D., Ph.D.Co-Founder, Chief Executive Officer, President, Executive Director and Ex Officio Member of Technology Committee
Regeneron Pharmaceuticals, Inc.
$3.3M
Paul M. Bisaro Chief Executive Officer, President and Director
Actavis, Inc.
$2.4M
J. Michael Pearson Chairman and Chief Executive Officer
Valeant Pharmaceuticals International, Inc.
$1.7M
Flemming Ornskov M.D., MBA, MPHChief Executive Officer, Head of Human Genetic Therapies and Director
Shire plc
--
Yoshihiko Hatanaka Chief Executive Officer, President and Representative Director
Astellas Pharma, Inc.
--
Compensation as of Fiscal Year 2012.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALLERGAN INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.